A collection of information about the FDA approved sickle cell treatments Endari™, Oxbryta™ and Adakveo®.
The Valentine family is hosting a blood drive in Lisle, IL on Saturday — Marqus’ birthday. The donations will go to Marqus’ home hospital, where he received many blood transfusions. Many patients with sickle cell disease (SCD) rely on blood transfusions for treatment.
This month’s blog post is written in honor of Marqus Valentine, Co-Founder of Sick Cells, and it is with a heavy heart that we share the news of his passing. Marqus was a truly passionate and dedicated advocate for the sickle cell community who fought tirelessly to raise awareness of the realities of living with SCD. Though we are heartbroken by the loss of our fiercest warrior, we are dedicated to continue working with you all to fight medical injustice and improve the lives of those affected by SCD for generations to come.
Sickle cell disease (SCD) is a severe red blood cell disorder that disproportionately affects African American and Hispanic populations. In the United States, there are approximately 100,000 individuals living with SCD (although there is a lack of accurate reporting and the exact number is unknown). Avalere Health and Sick Cells have partnered to examine how SCD is being managed during the COVID-19 Pandemic.